Valeant Makes Allergan Pitch, Reports Higher Profit

Valeant Pharmaceuticals posted improved second-quarter results and again made its case to acquire Allergan, but its financial guidance hurt shares.



from WSJ.com: US Business http://ift.tt/1ka9mX9

via IFTTT